97 related articles for article (PubMed ID: 21261727)
1. Reversal of hepatic steatosis by omega-3 fatty acids measured non-invasively by (1) H-magnetic resonance spectroscopy in a rat model.
Marsman HA; Heger M; Kloek JJ; Nienhuis SL; van Werven JR; Nederveen AJ; Ten Kate FJ; Stoker J; van Gulik TM
J Gastroenterol Hepatol; 2011 Feb; 26(2):356-63. PubMed ID: 21261727
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 fatty acids reduce hepatic steatosis and consequently attenuate ischemia-reperfusion injury following partial hepatectomy in rats.
Marsman HA; Heger M; Kloek JJ; Nienhuis SL; ten Kate FJ; van Gulik TM
Dig Liver Dis; 2011 Dec; 43(12):984-90. PubMed ID: 21840275
[TBL] [Abstract][Full Text] [Related]
3. Quantification of macrovesicular and microvesicular hepatic steatosis in rats using 3.0-T ¹H-magnetic resonance spectroscopy.
Ou HY; Chao PH; Yu PC; Wei YC; Chen CL; Yu CY; Chiu TM; Chang YC; Lai CY; Cheng YF
Transplant Proc; 2012 May; 44(4):955-8. PubMed ID: 22564595
[TBL] [Abstract][Full Text] [Related]
4. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885
[TBL] [Abstract][Full Text] [Related]
6. Hepatic regeneration and functional recovery following partial liver resection in an experimental model of hepatic steatosis treated with omega-3 fatty acids.
Marsman HA; de Graaf W; Heger M; van Golen RF; Ten Kate FJ; Bennink R; van Gulik TM
Br J Surg; 2013 Apr; 100(5):674-83. PubMed ID: 23456631
[TBL] [Abstract][Full Text] [Related]
7. Treatment with omega-3 fatty acids but not exendin-4 improves hepatic steatosis.
Bulchandani DG; Nachnani JS; Nookala A; Naumovitch C; Herndon B; Molteni A; Quinn T; Alba LM
Eur J Gastroenterol Hepatol; 2010 Oct; 22(10):1245-52. PubMed ID: 20651599
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease.
Alwayn IP; Gura K; Nosé V; Zausche B; Javid P; Garza J; Verbesey J; Voss S; Ollero M; Andersson C; Bistrian B; Folkman J; Puder M
Pediatr Res; 2005 Mar; 57(3):445-52. PubMed ID: 15659701
[TBL] [Abstract][Full Text] [Related]
9. Hepatic lipid composition analysis using 3.0-T MR spectroscopy in a steatotic rat model.
van Werven JR; Marsman HA; Nederveen AJ; ten Kate FJ; van Gulik TM; Stoker J
Magn Reson Imaging; 2012 Jan; 30(1):112-21. PubMed ID: 21940131
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive quantification of hepatic steatosis in rats using 3.0 T 1H-magnetic resonance spectroscopy.
Marsman HA; van Werven JR; Nederveen AJ; Ten Kate FJ; Heger M; Stoker J; van Gulik TM
J Magn Reson Imaging; 2010 Jul; 32(1):148-54. PubMed ID: 20578022
[TBL] [Abstract][Full Text] [Related]
11. Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model.
Veteläinen R; van Vliet A; van Gulik TM
J Gastroenterol Hepatol; 2007 Sep; 22(9):1526-33. PubMed ID: 17716355
[TBL] [Abstract][Full Text] [Related]
12. Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects.
Kurita S; Takamura T; Ota T; Matsuzawa-Nagata N; Kita Y; Uno M; Nabemoto S; Ishikura K; Misu H; Ando H; Zen Y; Nakanuma Y; Kaneko S
Eur J Pharmacol; 2008 Jul; 588(2-3):316-24. PubMed ID: 18501344
[TBL] [Abstract][Full Text] [Related]
13. Effects of iron overload in a rat nutritional model of non-alcoholic fatty liver disease.
Kirsch R; Sijtsema HP; Tlali M; Marais AD; Hall Pde L
Liver Int; 2006 Dec; 26(10):1258-67. PubMed ID: 17105592
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibitors improve hepatic steatosis by modulating expression of tumour necrosis factor-alpha, interleukin-6 and adiponectin receptor-2 in rats with type 2 diabetes.
Zhang X; Li ZZ; Liu DF; Xu X; Mei ZC; Shen W
Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):631-6. PubMed ID: 19076162
[TBL] [Abstract][Full Text] [Related]
15. COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator.
Yu J; Ip E; Dela Peña A; Hou JY; Sesha J; Pera N; Hall P; Kirsch R; Leclercq I; Farrell GC
Hepatology; 2006 Apr; 43(4):826-36. PubMed ID: 16557554
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 is associated with liver lipid homeostasis but not with cell death in experimental hepatic steatosis.
Sánchez-Garrido MA; Chico Y; González R; Ranchal I; González-Rubio S; Hidalgo AB; Díaz-López C; Costán G; Padillo FJ; De la Mata M; Ochoa B; Muntané J
Innate Immun; 2009 Dec; 15(6):337-49. PubMed ID: 19710104
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy.
Cussons AJ; Watts GF; Mori TA; Stuckey BG
J Clin Endocrinol Metab; 2009 Oct; 94(10):3842-8. PubMed ID: 19622617
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.
Kawaguchi K; Sakaida I; Tsuchiya M; Omori K; Takami T; Okita K
Biochem Biophys Res Commun; 2004 Feb; 315(1):187-95. PubMed ID: 15013444
[TBL] [Abstract][Full Text] [Related]
19. Utility of a 13C-methacetin breath test in evaluating hepatic injury in rats.
Shirin H; Aeed H; Shalev T; Sorin V; Stavinski S; Shahmurov M; Ilan Y; Avni Y
J Gastroenterol Hepatol; 2008 Nov; 23(11):1762-8. PubMed ID: 19120861
[TBL] [Abstract][Full Text] [Related]
20. Alleviation of hepatic steatosis accompanied by modulation of plasma and liver TNF-alpha levels by Trigonella foenum graecum (fenugreek) seeds in Zucker obese (fa/fa) rats.
Raju J; Bird RP
Int J Obes (Lond); 2006 Aug; 30(8):1298-307. PubMed ID: 16477270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
